KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Buildings (2016 - 2024)

Historic Buildings for Eli Lilly (LLY) over the last 13 years, with Q4 2024 value amounting to $8.8 billion.

  • Eli Lilly's Buildings rose 636.23% to $8.8 billion in Q4 2024 from the same period last year, while for Dec 2024 it was $8.8 billion, marking a year-over-year increase of 636.23%. This contributed to the annual value of $8.8 billion for FY2024, which is 636.23% up from last year.
  • As of Q4 2024, Eli Lilly's Buildings stood at $8.8 billion, which was up 636.23% from $8.3 billion recorded in Q4 2023.
  • Over the past 5 years, Eli Lilly's Buildings peaked at $8.8 billion during Q4 2024, and registered a low of $7.3 billion during Q4 2020.
  • For the 5-year period, Eli Lilly's Buildings averaged around $8.0 billion, with its median value being $7.9 billion (2022).
  • Per our database at Business Quant, Eli Lilly's Buildings soared by 357.63% in 2021 and then surged by 636.23% in 2024.
  • Quarter analysis of 5 years shows Eli Lilly's Buildings stood at $7.3 billion in 2020, then rose by 3.58% to $7.6 billion in 2021, then rose by 4.32% to $7.9 billion in 2022, then increased by 4.6% to $8.3 billion in 2023, then grew by 6.36% to $8.8 billion in 2024.
  • Its Buildings was $8.8 billion in Q4 2024, compared to $8.3 billion in Q4 2023 and $7.9 billion in Q4 2022.